General Information
Version
6.1
Revision date
2025-12-03
Product name
Molecular
Product name
Molecular
Identification on the label/Trade name
1.1. 1.1. Product identification
CAS No.
112253-70-0
1.2.1 Relevant identified uses
For laboratory research purposes.Not for drug or household use
Emergency telephone
1-352-323-3500
Icons in SDS
Company Information
company name
BLD Pharmatech GmbH
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H317
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
Physical hazards
Based on available data, the classification criteria are not met
Health hazards
Acute toxicity, oral Category 4 (H302) Sensitisation, skin Category 1, 1A, 1B (H317)
Environmental hazards
hazards Based on available data, the classification criteria are not met
2.2 Label elements
Signal
Signal word
Warning
Hazard statements
H302 - Harmful if swallowed H317 - May cause an allergic skin reaction Precautionary
Precautionary statements
P280 - Wear protective gloves/protective clothing/eye protection/face protection. 2.3. 2.3. Other hazards Results
Results of PBT and vPvB assessment
assessment
PBT Substances
Not applicable
vPvB Substances
Not applicable SECT ION 3: COMPOSIT ION/INFORMAT ION ION ON INGREDIENT INGREDIENT S S 3.1. 3.1. Substances CLP Classification - Component CAS-No Molecular Weight Weight Concentration Regulation (EC) (EC) No1272/2008 Acute toxicity, oral 4 (H302) 2-Amino-4-bromobenzamide 112253-70-0 215.05 ＜＝100% Sensitisation, skin 1, 1A, 1B (H317)
2.1 Classification of the substance or mixture
Acute toxicity, oral Category 4 (H302) Sensitisation, skin Category 1, 1A, 1B (H317) Environmental hazards hazards Based on available data, the classification criteria are not met 2.2. 2.2. Label elements Signal Signal Word Warning Hazard
